Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Benzylamine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113443996B reveals a Pt/SiC photocatalytic route for dibenzylamine. Achieve high selectivity and cost reduction in pharmaceutical intermediates manufacturing with scalable green chemistry.
Patent CN110003061B reveals a novel iron-catalyzed direct amination method. This technology offers significant cost reduction in pharmaceutical intermediate manufacturing and enhanced supply chain reliability.
Patent CN1273441C reveals a high-yield hydrogenation process for benzenedimethanamine. This method ensures catalyst longevity and supply chain stability for global buyers.
Novel patent CN111909040A offers cost-effective route for 2-fluoro-6-trifluoromethylbenzylamine ensuring high purity and supply chain stability for global pharmaceutical manufacturers.
Novel one-pot method for 4-tolyloxy benzylamine avoids hydrogenation, offering safer scale-up and cost efficiency for Tolfenpyrad production.
Patent CN108586267A reveals a high-yield synthesis route for 2,4,6-trifluorobenzylamine. This method ensures superior purity and cost-effective supply chain reliability.
Patent CN112194558B details a robust 3-step synthesis for a key pharmaceutical intermediate, offering high purity, scalable yields, and cost-effective manufacturing solutions.
Novel patent CN118652185B offers safer p-methoxybenzylamine production. Reduces hazardous reagents, ensures supply chain stability for pharmaceutical intermediate manufacturing.
Patent CN118652185B reveals a safer TiO2-catalyzed route for p-methoxybenzylamine. Discover cost reduction in pharmaceutical intermediate manufacturing and supply advantages.
Patent CN105461659A details a high-yield aminobenzylamine synthesis. Discover cost-effective, scalable manufacturing solutions for pharmaceutical intermediates.
Patent CN113372223B reveals a high-yield synthesis route for 2-fluoro-3-bromo-benzylamine, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN103965057A reveals a copper-catalyzed reduction method offering high purity and safety. Ideal for cost reduction in fine chemical manufacturing and supply chain reliability.
Patent CN102311352B details a safe, cost-effective 3-step synthesis from m-cresol, offering significant supply chain advantages for high-purity pharmaceutical intermediates.
Patent CN108752217B reveals a green, low-cost route for 2,4-difluorobenzylamine, a key dolutegravir intermediate, offering significant supply chain advantages.
Novel synthesis route for avanafil intermediate ensures high purity and safety. Cost-effective production scale-up for pharmaceutical supply chains globally seeking reliable partners.
Patent CN109320434B details a novel ionic iron(III) complex for direct C-H amination. This green technology offers significant cost reduction in fine chemical manufacturing and scalable production.
Patent CN104230853A details a robust synthesis route for pharmaceutical intermediates. This method offers significant supply chain reliability and cost optimization advantages.
Novel Raney-Ni catalyzed hydrogenation reduces steps for 2 4 6 trifluorobenzylamine ensuring high purity and cost reduction in pharma intermediate manufacturing.
Novel cyclic imide method for primary amines. Reduces waste, enhances supply chain reliability for pharmaceutical intermediates and fine chemical manufacturing.
Novel Raney Nickel catalytic method improves yield and reduces cost for capsaicinoid intermediates. Reliable supply chain partner for pharmaceutical manufacturing.